Recro Pharma, Inc. Stock Agreements
15 Contracts & Agreements
- Form of Inducement Award Agreement for Restricted Stock Units (Filed With SEC on August 9, 2021)
- Form of Non-Qualified Stock Option Inducement Award Agreement (Filed With SEC on August 9, 2021)
- Second Amendment to Common Stock Purchase Agreement, by and between Aspire Capital Fund, LLC and Recro Pharma, Inc., dated February 26, 2021 (Filed With SEC on February 26, 2021)
- Form of Award Agreement for Restricted Stock Units (Filed With SEC on February 26, 2021)
- Form of Non-Qualified Stock Option Award Agreement (Filed With SEC on February 26, 2021)
- Stock Issuance Agreement, dated as of February 19, 2021 by and between Recro Pharma, Inc., Athyrium Opportunities II Acquisition LP and Athyrium Opportunities III Acquisition LP (Filed With SEC on February 23, 2021)
- First Amendment to Common Stock Purchase Agreement, by and between Aspire Capital Fund, LLC and Recro Pharma, Inc., dated August 7, 2020 (Filed With SEC on August 10, 2020)
- Common Stock Purchase Agreement, dated February 19, 2019, by and between Recro Pharma, Inc. and Aspire Capital Fund, LLC (Filed With SEC on February 19, 2019)
- Common Stock Purchase Agreement, dated March 2, 2018, by and between Recro Pharma, Inc. and Aspire Capital Fund, LLC (Filed With SEC on March 2, 2018)
- Form of Award Agreement for Restricted Stock Unit Inducement Awards (Filed With SEC on March 2, 2018)
- [ ] Shares Recro Pharma, Inc. Common Stock PURCHASEAGREEMENT (Filed With SEC on December 1, 2016)
- 1,986,666 Shares RecroPharma, Inc. Common Stock PURCHASE AGREEMENT (Filed With SEC on August 17, 2016)
- COMMON STOCK PURCHASE AGREEMENT (Filed With SEC on February 3, 2015)
- RECRO PHARMA, INC. 2008 STOCK OPTION PLAN AWARD AGREEMENT FOR [employees name] (Filed With SEC on November 29, 2013)
- RECRO PHARMA, INC. 2008 STOCK OPTION PLAN (Filed With SEC on November 29, 2013)
